Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sachi Horibata

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
BMC Cancer|February 11, 2023
GDNF-RET signaling and EGR1 form a positive feedback loop that promotes tamoxifen resistance via cyclin D1Brooke A Marks, Ilissa M Pipia, Chinatsu Mukai, et al.
Plos One|April 4, 2018
A bi-stable feedback loop between GDNF, EGR1, and ERα contribute to endocrine resistant breast cancerSachi Horibata, Edward J Rice, Hui Zheng, et al.
Cell and Tissue Research|August 3, 2017
PAD2 overexpression in transgenic mice augments malignancy and tumor-associated inflammation in chemically initiated skin tumorsSunish Mohanan, Sachi Horibata, Lynne J Anguish, et al.
BMC Cancer|May 28, 2017
Role of peptidylarginine deiminase 2 (PAD2) in mammary carcinoma cell migrationSachi Horibata, Katherine E Rogers, David Sadegh, et al.
Translational Oncology|October 31, 2020
Cross-resistance of cisplatin selected cells to anti-microtubule agents: Role of general survival mechanismsRuchi P Patel, Skyler Kuhn, Da Yin, et al.
Cancer Research|September 13, 2014
PAD2 overexpression in transgenic mice promotes spontaneous skin neoplasiaJohn L McElwee, Sunish Mohanan, Sachi Horibata, et al.
Plos One|April 3, 2018
ER-positive breast cancer cells are poised for RET-mediated endocrine resistanceSachi Horibata, Edward J Rice, Chinatsu Mukai, et al.
Scientific Reports|November 12, 2025
Majusculamide-o, a simplified marine natural product analog, exhibits potent and specific cancer cell cytotoxicityNiklas Alexander Wahl, Naiara Lebrón-Acosta, Michelle Pérez-Cuevas, et al.
Molecular Cancer|June 3, 2014
MUC16 (CA125): tumor biomarker to cancer therapy, a work in progressMildred Felder, Arvinder Kapur, Jesus Gonzalez-Bosquet, et al.
Molecular Cancer|January 22, 2010
MUC16 provides immune protection by inhibiting synapse formation between NK and ovarian tumor cellsJennifer A A Gubbels, Mildred Felder, Sachi Horibata, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
BMC Cancer|February 11, 2023
GDNF-RET signaling and EGR1 form a positive feedback loop that promotes tamoxifen resistance via cyclin D1Brooke A Marks, Ilissa M Pipia, Chinatsu Mukai, et al.
Plos One|April 4, 2018
A bi-stable feedback loop between GDNF, EGR1, and ERα contribute to endocrine resistant breast cancerSachi Horibata, Edward J Rice, Hui Zheng, et al.
Cell and Tissue Research|August 3, 2017
PAD2 overexpression in transgenic mice augments malignancy and tumor-associated inflammation in chemically initiated skin tumorsSunish Mohanan, Sachi Horibata, Lynne J Anguish, et al.
BMC Cancer|May 28, 2017
Role of peptidylarginine deiminase 2 (PAD2) in mammary carcinoma cell migrationSachi Horibata, Katherine E Rogers, David Sadegh, et al.
Translational Oncology|October 31, 2020
Cross-resistance of cisplatin selected cells to anti-microtubule agents: Role of general survival mechanismsRuchi P Patel, Skyler Kuhn, Da Yin, et al.
Cancer Research|September 13, 2014
PAD2 overexpression in transgenic mice promotes spontaneous skin neoplasiaJohn L McElwee, Sunish Mohanan, Sachi Horibata, et al.
Plos One|April 3, 2018
ER-positive breast cancer cells are poised for RET-mediated endocrine resistanceSachi Horibata, Edward J Rice, Chinatsu Mukai, et al.
Scientific Reports|November 12, 2025
Majusculamide-o, a simplified marine natural product analog, exhibits potent and specific cancer cell cytotoxicityNiklas Alexander Wahl, Naiara Lebrón-Acosta, Michelle Pérez-Cuevas, et al.
Molecular Cancer|June 3, 2014
MUC16 (CA125): tumor biomarker to cancer therapy, a work in progressMildred Felder, Arvinder Kapur, Jesus Gonzalez-Bosquet, et al.
Molecular Cancer|January 22, 2010
MUC16 provides immune protection by inhibiting synapse formation between NK and ovarian tumor cellsJennifer A A Gubbels, Mildred Felder, Sachi Horibata, et al.
Pageof 4